Sivik Global Healthcare LLC Purchases New Holdings in The Cigna Group (NYSE:CI)

Sivik Global Healthcare LLC bought a new position in The Cigna Group (NYSE:CI) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 12,000 shares of the health services provider’s stock, valued at approximately $3,314,000. The Cigna Group comprises about 1.7% of Sivik Global Healthcare LLC’s holdings, making the stock its 25th biggest position.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Algert Global LLC purchased a new stake in The Cigna Group during the second quarter valued at $523,000. NewEdge Advisors LLC boosted its stake in shares of The Cigna Group by 36.5% in the second quarter. NewEdge Advisors LLC now owns 19,522 shares of the health services provider’s stock worth $6,453,000 after acquiring an additional 5,224 shares during the period. Northwestern Mutual Wealth Management Co. grew its position in shares of The Cigna Group by 1.3% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 20,675 shares of the health services provider’s stock worth $6,836,000 after purchasing an additional 272 shares in the last quarter. EP Wealth Advisors LLC raised its stake in The Cigna Group by 13.2% during the 2nd quarter. EP Wealth Advisors LLC now owns 5,434 shares of the health services provider’s stock valued at $1,796,000 after purchasing an additional 633 shares during the period. Finally, Cetera Investment Advisers lifted its holdings in The Cigna Group by 1.4% in the 2nd quarter. Cetera Investment Advisers now owns 63,156 shares of the health services provider’s stock worth $20,878,000 after purchasing an additional 895 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

The Cigna Group Price Performance

Shares of NYSE CI opened at $279.07 on Thursday. The firm has a market cap of $77.62 billion, a P/E ratio of 25.44, a P/E/G ratio of 0.78 and a beta of 0.54. The business’s 50 day moving average price is $296.45 and its 200 day moving average price is $325.14. The Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.71.

The Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. During the same period in the previous year, the company posted $6.79 EPS. On average, sell-side analysts expect that The Cigna Group will post 28.5 earnings per share for the current year.

Analyst Ratings Changes

Several research firms have recently issued reports on CI. StockNews.com cut shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Piper Sandler reaffirmed an “overweight” rating and issued a $394.00 target price (up from $392.00) on shares of The Cigna Group in a report on Tuesday, November 5th. Cantor Fitzgerald reissued an “overweight” rating and set a $400.00 price target on shares of The Cigna Group in a research note on Wednesday, October 23rd. Stephens restated an “overweight” rating and issued a $410.00 target price on shares of The Cigna Group in a report on Friday, November 1st. Finally, Barclays increased their price target on shares of The Cigna Group from $405.00 to $420.00 and gave the company an “overweight” rating in a report on Tuesday, November 5th. One investment analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $395.93.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.